Abstract: A powered ankle-foot prosthesis, capable of providing human-like power at terminal stance that increase amputees metabolic walking economy compared to a conventional passive-elastic prosthesis. The powered prosthesis comprises a unidirectional spring, configured in parallel with a force-controllable actuator with series elasticity. The prosthesis is controlled to deliver the high mechanical power and net positive work observed in normal human walking.
Type:
Grant
Filed:
November 6, 2018
Date of Patent:
March 22, 2022
Assignee:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Inventors:
Hugh M. Herr, Jeff A. Weber, Kwok Wai Samuel Au, Bruce Wayne Deffenbaugh, Lee Harris Magnusson, Andreas G. Hofmann, Benjamin B. Aisen
Abstract: The present invention provides novel peptides (e.g., peptides, macrocyclic peptides, mini-proteins) that modulate protein-protein interactions or salts thereof, and methods of making and using the inventive peptides. In some embodiments, the peptides are high affinity inhibitors (e.g., KD of at most 100 nM, at most 10 nM, at most 1 nM) of a protein-protein interaction. In certain embodiments, these peptides interfere with p53-MDM2 binding interactions (e.g., by binding to MDM2 (GenBankĀ® Gene ID: 4193)). In some embodiments, the peptides interfere with the dimerization of the C-terminal domain of the human immunodeficiency virus (HIV) capsid protein (C-CA), comprising residues 146-231 of the HIV capsid protein (e.g., by binding to the C-terminal domain of the HIV capsid protein (C-CA), thereby inhibiting the dimeric interface of HIV capsid protein, thereby inhibiting viral assembly).
Abstract: The invention, in some aspects, relates to dummy-fluorescent (DF) polypeptide molecules and their encoding nucleic acid molecules and use of such molecules in fusion proteins and their encoding nucleic acid molecules. Compositions of the invention may be delivered to cells and subjects and used in methods to modulate electrical activity of cells in which they are expressed, and for treatment of diseases and conditions in subjects.
Type:
Grant
Filed:
July 20, 2017
Date of Patent:
March 22, 2022
Assignee:
Massachusetts Institute of Technology
Inventors:
Aimei Yang, Demian Park, Kiryl Piatkevich, Edward Boyden
Abstract: A prosthetic device includes a frame defining an output axis, a cantilever beam spring attached to the frame, a moment arm attached to the spring, and a rigid output arm coupled to the frame and rotatable about the output axis. A connector assembly is configured to apply a moment to the cantilever beam spring via the moment arm while applying a torque about the output axis via the output arm. An ankle-foot device includes foot and ankle members connected for two-degree of freedom movement relative to one another, allowing for rotation about an ankle axis and rotation about a subtalar axis. Two linear actuators, each coupled to corresponding series elastic element, link the foot and ankle members. Driving the actuators in the same direction causes rotation about the ankle axis and driving the actuators in opposing directions causes rotation about the subtalar axis. A processor receives sensory information from a sensor and drives the actuators to control an equilibrium position of the series elastic elements.
Type:
Grant
Filed:
October 23, 2019
Date of Patent:
March 22, 2022
Assignee:
Massachusetts Institute of Technology
Inventors:
Hugh M. Herr, Matthew Eli Carney, Emily Ann Rogers, Lucy Wei Du
Abstract: Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface (e.g., a surface of a tissue of a subject). The self-righting articles described herein may comprise one or more tissue engaging surfaces configured to engage (e.g., interface with, inject into, anchor) with a surface (e.g., a surface of a tissue of a subject). In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In some embodiments, the self-righting article may comprise a tissue interfacing component and/or a pharmaceutical agent (e.g., for delivery of the active pharmaceutical agent to a location internal of the subject).
Type:
Application
Filed:
May 17, 2018
Publication date:
March 17, 2022
Applicants:
Massachusetts Institute of Technology, The Brigham and Woman's Hospital, Inc.
Inventors:
Carlo Giovanni Traverso, Alex G. Abramson, Ester Caffarel Salvador, Niclas Roxhed, Minsoo Khang, Taylor Bensel, Robert S. Langer
Abstract: Nitrogen vacancy (NV) centers in diamond combine exceptional sensitivity with nanoscale spatial resolution by optically detected magnetic resonance (ODMR). Infrared (IR)-absorption-based readout of the NV singlet state transition can increase ODMR contrast and collection efficiency. Here, a resonant diamond metallodielectric metasurface amplifies IR absorption by concentrating the optical field near the diamond surface. This plasmonic quantum sensing metasurface (PQSM) supports plasmonic surface lattice resonances and balances field localization and sensing volume to optimize spin readout sensitivity. Combined electromagnetic and rate-equation modeling suggests a near-spin-projection-noise-limited sensitivity below 1 nT Hz?1/2 per m2 of sensing area using numbers for contemporary NV diamond samples and fabrication techniques.
Type:
Application
Filed:
July 15, 2021
Publication date:
March 17, 2022
Applicant:
Massachusetts Institute of Technology
Inventors:
Laura KIM, Hyeongrak CHOI, Matthew Edwin TRUSHEIM, Dirk Robert ENGLUND
Abstract: The invention, in some aspects relates to compositions and methods for altering cell activity and function and the introduction and use of light-activated ion channels.
Type:
Grant
Filed:
May 28, 2020
Date of Patent:
March 15, 2022
Assignees:
Massachusetts Institute of Technology, The Governors of the University of Alberta
Inventors:
Nathan Klapoetke, Brian Yichiun Chow, Edward Boyden, Gane Ka-Shu Wong, Yongku Peter Cho
Abstract: An artificial foot and ankle joint consists of a curved leaf spring foot member having a heel extremity and a toe extremity, and a flexible elastic ankle member that connects the foot member for rotation at the ankle joint. An actuator motor applies torque to the ankle joint to orient the foot when it is not in contact with the support surface and to store energy in a catapult spring that is released along with the energy stored in the leaf spring to propel the wearer forward. A ribbon clutch prevents the foot member from rotating in one direction beyond a predetermined limit position. A controllable damper is employed to lock the ankle joint or to absorb mechanical energy as needed. The controller and sensing mechanisms control both the actuator motor and the controllable damper at different times during the walking cycle for level walking, stair ascent, and stair descent.
Type:
Grant
Filed:
July 1, 2019
Date of Patent:
March 15, 2022
Assignee:
Massachusetts Institute of Technology
Inventors:
Hugh M. Herr, Kwok Wai Samuel Au, Daniel Joseph Paluska, Peter Dilworth
Abstract: Voltage reporter molecules and compositions, and methods for detecting voltage and voltage change in cells are provided. Also provided are methods for delivery, expression, and use of the voltage reporter molecules in cells, tissues, and subjects.
Type:
Grant
Filed:
July 3, 2018
Date of Patent:
March 15, 2022
Assignee:
Massachusetts Institute of Technology
Inventors:
Edward Boyden, Kiryl Piatkevich, Eunjung Jung
Abstract: An improved waveguide is disclosed. The waveguide utilizes a luminescent material disposed within or around its perimeter to introduce additional light into the waveguide. For example, the waveguide may include a plurality of planar layers having different refractive indexes. A luminescent material may be disposed along the outer edge of these layers. When light from within the waveguide strikes the luminescent material, it emits light, thereby adding to the light in the waveguide. Not only does the luminescent material introduce more light into the waveguide, it also introduces more light sources, thereby making it more difficult to introduce a probe without blocking at least a portion of the light destined for the image sensor. The luminescent material may be a phosphor.
Type:
Grant
Filed:
July 1, 2020
Date of Patent:
March 15, 2022
Assignee:
Massachusetts Institute of Technology
Inventors:
Michael W. Geis, Joshua Kramer, Karen M. G. V. Gettings, Marc J. Burke, Mankuan M. Vai, Theodore M. Lyszczarz
Abstract: A programmable modular protein architecture for RNA binding comprises a set of modules, derived from RNA-binding protein Pumilio, that can be concatenated into chains of varying composition and length. When bound into a chain, each module has a preferred affinity for a specific RNA base. The chains can bind arbitrary RNA sequences with high specificity and fidelity by varying the sequence of modules within the chains. Each module contains at least 6 amino acids, with the amino acids in positions 1 and 5 providing the preferred affinity for the specific base, and the amino acid at position 2 serving as a stacking unit between concatenated modules. The modules may have four canonic forms, each having a preferred affinity for a different base and characterized by the base with which it has affinity, the two amino acids that provide the affinity, and the amino acid that serves as a stacking unit.
Type:
Grant
Filed:
June 25, 2019
Date of Patent:
March 15, 2022
Assignee:
Massachusetts Institute of Technology
Inventors:
Edward S. Boyden, Katarzyna P. Adamala, Daniel Alberto Martin-Alarcon
Abstract: Articles and methods for processing aluminum are generally described. The aluminum can include compositions of gallium and/or indium such that the aluminum is activated to react with water.
Abstract: Described herein are methods and compositions related to a method of treating a neurodevelopmental disorder in a subject in need thereof, the method comprises administering to the subject an agent that increases the level or activity of interleukin-17a (IL-17a) in the brain. The method can further comprise administering an agent that increases the permeability of the blood brain barrier.
Type:
Application
Filed:
January 9, 2020
Publication date:
March 10, 2022
Applicants:
President and Fellows of Haravrd College, Massachusetts Institute of Technology
Abstract: A method and system for medical imaging employs an excitation source configured to cause an object having a plurality of cells to at least one of emit, reflect, and fluoresce light. An optical receptor is employed that is configured to receive the light from the object. A filter assembly receives the light from the optical receptor and filters the light. An image processor having a field of view (FOV) substantially greater than a diameter of a cell of the object and an analysis resolution substantially matched to the diameter of a cell of the object that receives the filtered light from the filter and analyzes the filtered light corresponding to each cell in the FOV. A feedback system is provided that is configured to provide an indication of a state of each cell in the FOV and a location of a cell in the FOV meeting a predetermined condition.
Type:
Grant
Filed:
February 6, 2015
Date of Patent:
March 8, 2022
Assignees:
Massachusetts Institute of Technology, Duke University
Inventors:
Moungi G. Bawendi, Jorge M. Ferrer, W. David Lee, Lisa F. Marshall, David G. Kirsch
Abstract: An integrated circuit chip and method for EEG monitoring. In one embodiment, the integrated circuit chip includes an Analog Front End cell in communication with an electrode and a Classification Processor wherein a signal received from the electrode is processed by the Classification Engine cell and designated as seizure or non-seizure. In another embodiment, the Analog Front End cell includes an amplifier cell in communication with an electrode; and an ASPU cell in communication with the amplifier cell. In yet another embodiment, the Classification Processor includes a DBE Channel Controller cell; a Feature Extraction Engine Processor cell, and a Classification Engine cell in communication with the Feature Extraction Engine Processor cells and the DBE Channel Controller cell.
Type:
Grant
Filed:
April 17, 2018
Date of Patent:
March 8, 2022
Assignees:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Inventors:
Jerald Yoo, Anantha P. Chandrakasan, Long Yan, Dina Reda El-Damak, Ali Hossam Shoeb, Muhammad Awais Bin Altaf
Abstract: A technology called RINSE (Removal of Incubated Nanotubes through Selective Exfoliation) is demonstrated. RINSE removes carbon nanotube (CNT) aggregates in CNFETs without compromising CNFET performance. In RINSE, CNTs are deposited on a substrate, coated with a thin adhesive layer, and sonicated. The adhesive layer is strong enough to keep the individual CNTs on the substrate, but not the larger CNT aggregates. When combined with a CNFET CMOS process as disclosed here, record CNFET CMOS yield and uniformity can be realized.
Abstract: In general, the present invention is directed to materials that when in use resist fouling on their surfaces. Such materials may be used in the construction of various process equipment having surfaces exposed to a given fluid that contains a foulant or chemical substance that may deposit on, or adhere to, the surface and thereafter continue to grow on the surface resulting in deteriorated performance of the equipment and process. The materials are specifically selected using a method that takes into account the dielectric spectra of the fluid to which the surface is exposed and the surface itself. It has been unexpectedly found that if the dielectric spectra of the surface and the fluid are matched to within relative agreement, there should be no adhesion of the foulant on the surface. In some embodiments, the dielectric spectra to be matched include the intrinsic indexes of refraction.
Abstract: Isolated monoclonal antibodies which bind to Zika virus envelope protein and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.
Type:
Grant
Filed:
October 13, 2017
Date of Patent:
March 8, 2022
Assignees:
Massachusetts Institute of Technology, National University of Singapore
Inventors:
Ram Sasisekharan, Kannan Tharakaraman, Kuan Rong Chan, Satoru Watanabe, Subhash G. Vasudevan, Eng Eong Ooi
Abstract: In a method for generating an elongated nucleic acid molecule, a nucleic acid addition of a first nucleic acid molecule attached to a first 3? or 5? protecting group to a nucleic acid immobilized on a surface produces an intermediate-length immobilized nucleic acid. The first protecting group is dissociated from the first nucleic acid molecule. A second nucleic acid molecule that is attached to a second associated a 3? or 5? associated protecting group is added to the intermediate-length nucleic acid. The second associated protecting group is dissociated from the second nucleic acid molecule. A sequentially-extended elongated immobilized nucleic acid molecule having a desired sequence and length is produced by sequentially extending the intermediate-length immobilized nucleic acid by adding additional nucleic acid molecules with associated protecting groups to the intermediate-length nucleic acid and dissociating the associated protecting group after each addition.
Type:
Grant
Filed:
November 22, 2016
Date of Patent:
March 8, 2022
Assignee:
Massachusetts Institute of Technology
Inventors:
Peter A. Carr, Brian Y. Chow, Joseph M. Jacobson, David W. Mosley, Christopher Emig